Researchers discover how to control the anomalous Hall effect and Berry curvature to create flexible quantum magnets for use in computers, robotics, and sensors.

The device detects the same molecules that cell receptors do, and may enable routine early screening for cancers and other diseases.

Visolis, founded by Deepak Dugar SM ’11, MBA ’13, PhD ’13, is working to decarbonize the production of everything from rubber to jet fuel.

A new approach opens the door to a greater understanding of protein-microbe interactions.

Mathias Kolle’s color-changing materials take inspiration from butterflies and mollusks.

A new technology called RIBOmap can give researchers valuable insight into how protein production in animal and human tissue is altered in disease.

A pilot-scale system, enabled by an $82 million award from the FDA, aims to accelerate the development and production of mRNA technologies.

MIT researchers develop "FrameDiff," a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.

This AI system only needs a small amount of data to predict molecular properties, which could speed up drug discovery and material development.

New soft-bodied robots that can be controlled by a simple magnetic field are well suited to work in confined spaces.